AstraZeneca&#39;s MedImmune buy gets U.S. antitrust nod
681404
U.S. antitrust authorities on  Wednesday approved AstraZeneca Plc&#39;s  plan to buy  biotechnology company MedImmune Inc.  for more than $15  billion.
702047
A U.S. judge has ordered  pharmaceutical companies AstraZeneca  and Bristol-Myers  Squibb Co  to pay double damages in a case over false  mark ups of U.S. drug prices through 2003, according to court  documents filed on Friday.
355967
OXiGENE reaches a deal with FDA on its lead compound.
594552
LONDON (CBS.MW) -- Pharmaceutical maker AstraZeneca (UK:AZN) (AZN) said it&#39;s investing 75 million British pounds ($139 million) in cash for a 19.9 percent stake in UK biotech group Cambridge Antibody Technology (UK:CAT) (CATG) as part of a five year, R&amp;D
738382
The drug maker is poised to speed past its rivals.
678824
GlaxoSmithKline Plc won approval to sell an over-the-counter weight loss drug called Alli in the United States, the company and U.S. health officials said on Wednesday.
64992
Medarex Inc., a Princeton, NJ, biotechnology company, could receive up to $510 million under a global collaboration deal it signed with New York-based Pfizer Inc.
460971
Will AstraZeneca become the latest casualty in the drug safety debate?
79616
AstraZeneca Plc, the UK&#39;s second largest drugmaker, said US regulators approved its ulcer treatment Nexium for use in reducing the risk of stomach ulcers in patients taking certain painkillers
406531
Cambridge Antibody Technology has announced an alliance with pharmaceutical giant AstraZeneca after posting a slightly narrower annual loss before tax.
600129
Anglo-Swedish drugs giant AstraZeneca and British peer GlaxoSmithKline said Wednesday they had been approached by EU regulators as part of an antitrust probe into the pharmaceutical sector.
288984
Spectrum Pharmaceuticals SPPI.O said  on Friday U.S. regulators have approved its generic version of  Bayer's BAYG.DE  Cipro antibiotic, triggering a $750,000  equity investment by one of its partners.
583185
Consolidation in Europe's drugs  sector gathered steam on Thursday as Germany's Merck unveiled a  $13.3-billion deal to buy Europe's top biotech firm Serono, and  Denmark's Nycomed won the drugs unit of Altana.
510581
AstraZeneca Plc has won US approval to market its Nexium ulcer pill as a treatment that reduces the risk of ulcers developing in patients on non-steroidal anti-inflammatory drugs, it said on Monday.
407814
Shares in Irish drug group Elan Corp. PLC are expected to be in demand today, as investors react to news that Antegren, its multiple sclerosis (MS) drug now known as Tysabri, was granted accelerated approval by the US FDA last night.
150005
Swiss biotech firm Serono SA, which earlier Thursday agreed to sell a majority stake in the company to German drugmaker Merck KGaA for $13.31 billion, said its oral cladribine treatment for multiple sclerosis has received "fast-track" status from the U.S. Food and Drug Administration.
142281
FDA advisory panel gives the nod to its heart drug.